NexGel Return on Tangible Equity 2021-2025 | NXGL

Current and historical return on tangible equity values for NexGel (NXGL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
NexGel Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2025-03-31 $0.00B $0.00B -114.29%
2024-12-31 $0.00B $0.00B -114.29%
2024-09-30 $0.00B $0.00B -114.29%
2024-06-30 $0.00B $0.00B -94.12%
2024-03-31 $0.00B $0.00B -80.00%
2023-12-31 $0.00B $0.00B -69.57%
2023-09-30 $0.00B $0.01B -61.54%
2023-06-30 $0.00B $0.01B -57.14%
2023-03-31 $0.00B $0.01B -51.61%
2022-12-31 $-0.01B $0.01B -58.82%
2022-09-30 $-0.01B $0.01B -61.54%
2022-06-30 $-0.01B $0.01B -77.42%
2022-03-31 $-0.01B $0.01B -109.09%
2021-12-31 $-0.01B $0.01B -153.85%
2021-09-30 $0.00B $0.00B -1600.00%
2021-06-30 $0.00B $0.00B -1600.00%
2021-03-31 $0.00B $0.00B -1600.00%
2020-12-31 $0.00B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.017B $0.009B
NexGel Inc. is a provider of ultra-gentle, high-water-content hydrogels for healthcare and consumer applications. The company developed and manufactured electron-beam, cross-linked hydrogels. NexGel Inc. is based in Langhorne, Pa.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $189.818B 83.14
Thermo Fisher Scientific (TMO) United States $156.486B 18.93
Edwards Lifesciences (EW) United States $44.464B 29.15
Alcon (ALC) Switzerland $43.874B 29.65
IDEXX Laboratories (IDXX) United States $42.296B 48.61
DexCom (DXCM) United States $33.259B 51.41
IQVIA Holdings (IQV) United States $27.640B 15.48
Mettler-Toledo (MTD) United States $25.284B 30.07
STERIS (STE) Ireland $23.842B 26.26
Waters (WAT) United States $20.819B 29.37
SONOVA HOLDING (SONVY) Switzerland $18.720B 0.00
Hologic (HOLX) United States $14.516B 15.77
Sysmex ADR (SSMXY) Japan $10.481B 29.73
Penumbra (PEN) United States $9.903B 77.73
Masimo (MASI) United States $9.110B 33.61
Globus Medical (GMED) United States $8.322B 19.83
Teleflex (TFX) United States $5.543B 9.15
Glaukos (GKOS) United States $5.465B 0.00
TransMedics (TMDX) United States $4.764B 103.57
Integer Holdings (ITGR) United States $4.275B 22.40
PROCEPT BioRobotics (PRCT) United States $3.554B 0.00
LivaNova (LIVN) United Kingdom $2.595B 15.45
Veracyte (VCYT) United States $2.183B 30.64
Nihon Kohden (NHNKY) Japan $2.111B 24.21
Elekta AB (EKTAY) Sweden $1.910B 17.17
Alphatec Holdings (ATEC) United States $1.785B 0.00
Tandem Diabetes Care (TNDM) United States $1.495B 0.00
Artivion (AORT) United States $1.249B 116.96
Pulse Biosciences (PLSE) United States $1.167B 0.00
OPKO Health (OPK) United States $1.094B 0.00
Integra LifeSciences Holdings (IART) United States $1.086B 5.78
Beta Bionics (BBNX) United States $0.835B 0.00
SiBone (SIBN) United States $0.814B 0.00
IRadimed (IRMD) United States $0.762B 38.67
RxSight (RXST) United States $0.638B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.597B 9.29
Mesa Laboratories (MLAB) United States $0.569B 13.34
Delcath Systems (DCTH) United States $0.565B 0.00
OrthoPediatrics (KIDS) United States $0.538B 0.00
AxoGen (AXGN) United States $0.486B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.453B 0.00
AngioDynamics (ANGO) United States $0.452B 0.00
NeuroPace (NPCE) United States $0.424B 0.00
Treace Medical Concepts (TMCI) United States $0.388B 0.00
ClearPoint Neuro (CLPT) United States $0.372B 0.00
Semler Scientific (SMLR) United States $0.351B 9.35
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
908 Devices (MASS) United States $0.255B 0.00
Neuronetics (STIM) United States $0.249B 0.00
Tactile Systems Technology (TCMD) United States $0.241B 14.58
Alpha Tau Medical (DRTS) Israel $0.217B 0.00
Sight Sciences (SGHT) United States $0.216B 0.00
Anteris Technologies Global (AVR) Australia $0.193B 0.00
Biosig Technologies (BSGM) United States $0.182B 0.00
Inogen (INGN) United States $0.178B 0.00
Spectral Diagnostics (EDTXF) Canada $0.171B 0.00
CVRx (CVRX) United States $0.170B 0.00
Rapid Micro Biosystems (RPID) United States $0.157B 0.00
LENSAR (LNSR) United States $0.152B 0.00
Lucid Diagnostics (LUCD) United States $0.141B 0.00
Accuray (ARAY) United States $0.132B 0.00
Atossa Genetics (ATOS) United States $0.114B 0.00
Monogram Orthopaedics (MGRM) United States $0.096B 0.00
Microbot Medical (MBOT) United States $0.095B 0.00
Sensus Healthcare (SRTS) United States $0.084B 51.30
EnVVeno Medical (NVNO) United States $0.076B 0.00
InspireMD (NSPR) United States $0.075B 0.00
EDAP TMS S.A (EDAP) France $0.064B 0.00
Hyperfine (HYPR) United States $0.062B 0.00
Spectral AI (MDAI) United States $0.053B 0.00
Positron (POSC) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.047B 0.00
Precision Optics (POCI) United States $0.036B 0.00
DarioHealth (DRIO) United States $0.032B 0.00
Envoy Medical (COCH) United States $0.032B 0.00
Baird Medical Investment Holdings (BDMD) $0.027B 0.00
Adagio Medical Holdings (ADGM) United States $0.019B 0.00
WORK Medical Technology Group (WOK) China $0.012B 0.00
PAVmed (PAVM) United States $0.011B 0.00
Ekso Bionics Holdings (EKSO) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.007B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
Autonomix Medical (AMIX) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Bluejay Diagnostics (BJDX) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.001B 0.00
Accelerate Diagnostics (AXDX) United States $0.001B 0.00
Helius Medical Technologies (HSDT) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $0.000B 16.37
Longview Acquisition II (LGV) United States $0.000B 0.00